Similar articles

• ASHG Statement* on direct-to-consumer genetic testing in the United States.

  Hudson K, Javitt G, Burke W, Byers P; American Society of Human Genetics Social Issues Committee. Hudson K, et al. Obstet Gynecol. 2007 Dec;110(6):1392-5. doi: 10.1097/01.AOG.0000292086.98514.8b. Obstet Gynecol. 2007. PMID: 18055737 No abstract available.
• Are doctors prepared for direct-to-consumer advertising of genetic tests?

  Mennuti M. Mennuti M. Obstet Gynecol. 2008 Apr;111(4):991, author reply 991. doi: 10.1097/AOG.0b013e31816bfd1e. Obstet Gynecol. 2008. PMID: 18378761 No abstract available.
• Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.

  Javitt GH, Stanley E, Hudson K. Javitt GH, et al. Oklahoma Law Rev. 2004 Summer;57(2):251-302. Oklahoma Law Rev. 2004. PMID: 15658034 No abstract available.
• Direct-to-consumer genetic testing: the need to get retail genomics right.

  Schickedanz AD, Herdman RC. Schickedanz AD, et al. Clin Pharmacol Ther. 2009 Jul;86(1):17-20. doi: 10.1038/clpt.2009.56. Clin Pharmacol Ther. 2009. PMID: 19536118 Review. No abstract available.
• Are we ready for direct-to-consumer genetic testing?

  Burton A. Burton A. Lancet Neurol. 2015 Feb;14(2):138-9. doi: 10.1016/S1474-4422(15)70003-7. Lancet Neurol. 2015. PMID: 25772890 Review. No abstract available.